CMR-based radiomics shows considerable potential for improving diagnosis and phenotypic characterization of cardiomyopathies, but methodological standardization, multicenter prospective validation, and demonstration of incremental clinical value are required before routine clinical implementation.
Abstract
Background: Cardiovascular magnetic resonance (CMR) is the reference non-invasive imaging modality for evaluating cardiomyopathies, providing comprehensive assessment of cardiac morphology, function, and tissue characterization. Radiomics has recently emerged as an advanced image analysis technique that extracts quantitative imaging biomarkers from routine CMR images, potentially enhancing disease characterization beyond conventional visual assessment. This systematic review summarizes current evidence on the role of CMR-based radiomics in the diagnosis, phenotypic characterization and risk stratification of cardiomyopathies. Methods: A structured search identified English-language, peer-reviewed studies published up to August 2026 investigating CMR-based radiomics in hypertrophic, dilated, arrhythmogenic, and infiltrative cardiomyopathies, including cardiac amyloidosis, Fabry disease, and cardiac sarcoidosis. Study selection followed PRISMA 2020 guidelines. Methodological quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS) and the Radiomics Quality Score 2.0 (RQS 2.0) The authors have reviewed and edited the output and take full responsibility for the content of this publication. Results: Current evidence indicates that CMR radiomics provides incremental diagnostic information beyond conventional CMR by quantifying myocardial tissue heterogeneity. Radiomic features derived from cine imaging, late gadolinium enhancement, native T1/T2 mapping, and extracellular volume maps showed promising performance in differentiating cardiomyopathy subtypes, distinguishing pathological from physiological remodeling, and identifying infiltrative and inflammatory myocardial diseases. Multiparametric radiomic models generally outperformed individual imaging biomarkers, with preliminary evidence supporting applications in risk stratification and outcome prediction. However, studies were predominantly retrospective, involved small cohorts, used heterogeneous imaging and radiomics workflows, and rarely included external validation. RQS 2.0 assessment demonstrated low-to-moderate methodological quality. Conclusions: CMR-based radiomics shows considerable potential for improving diagnosis and phenotypic characterization of cardiomyopathies. However, methodological standardization, multicenter prospective validation, and demonstration of incremental clinical value are required before routine clinical implementation.
Myocardial fibrosis (MF) is a key determinant of adverse outcomes in severe aortic stenosis and limits the efficacy of valve implantation. Endomyocardial biopsy is the reference standard for diagnosing MF, but its invasiveness limits routine use. Cardiovascular magnetic resonance (CMR)-derived extracellular volum...
K. Steinhaus, M. Maurer, J. Gronwald et al.· European Heart Journal· 0 citations
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic and phenotypic myocardial disease where diagnosis and risk stratification extend beyond the mere detection of left ventricular hypertrophy. While echocardiography is the first-line imaging modality, this approach often offers limited insights into disease eti...
Karim Ali, Ahmed E. Ali, Mohamed K. A. Awad et al.· Reviews in cardiovascular me...· 0 citations
Hypertrophic cardiomyopathy (HCM) is a genetically and phenotypically heterogeneous myocardial disease characterized by unexplained left ventricular hypertrophy and a broad spectrum of clinical manifestations, ranging from an asymptomatic phenotype to heart failure, atrial and ventricular arrhythmias, sudden cardiac de...
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that is underdiagnosed until advanced stages. Non-invasive imaging modalities, including echocardiography, cardiovascular magnetic resonance (CMR), bone scintigraphy, positron emission tomography (PET), and computed tomography (CT), have transformed diagn...
K. Singhal, V. Patel, N. Doobay et al.· European Heart Journal· 0 citations
This consensus document summarizes the current role of cardiovascular magnetic resonance (CMR) in contemporary cardiology practice. It integrates the latest evidence, international guideline recommendations, and practical experience regarding the use of CMR in the diagnosis and management of the most common cardiovascu...
O. Stukalova, S. Aleksandrova, T. Dautov et al.· Eurasian heart journal· 0 citations
Heart failure (HF) is a global health priority traditionally managed based on ejection fraction (EF). However, EF is now recognized as insufficient to represent the pathophysiological complexity and clinical heterogeneity of the syndrome. Modern diagnostics have shifted toward multimodality imaging, acting as an integr...
F. Musella, S. Carigi, Denitza Tinti et al.· Giornale italiano di cardiol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.